Savara Inc Added to NASDAQ Biotechnology Index.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.055 USD | -4.36% | -1.05% | -13.47% |
May. 21 | Oppenheimer Adjusts Savara Price Target to $11 From $9.50, Maintains Outperform Rating | MT |
May. 09 | Savara Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.47% | 586M | |
+18.57% | 125B | |
+13.89% | 109B | |
-3.38% | 24.74B | |
+2.71% | 22.67B | |
-9.95% | 18.14B | |
-41.48% | 16.67B | |
-12.15% | 16.64B | |
+0.52% | 13.45B | |
+22.37% | 11.32B |
- Stock Market
- Equities
- SVRA Stock
- News Savara Inc.
- Savara Inc.(NasdaqGS: SVRA) added to NASDAQ Biotechnology Index